Related Experiment Video
Updated: Aug 17, 2026

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry
Published on: May 17, 2016
Inhibition of in vitro myogenic differentiation by cellular transcription factor E2F1
1Department of Cardiology, Children's Hospital, Boston, Massachusetts 02135, USA.
Abstract:
Terminal differentiation of cultured myocytes requires withdrawal of the cells from the cell cycle. Constitutive overexpression of several oncogenes in myoblasts can inhibit in vitro myogenesis. Here we studied the role of the cellular transcription factor E2F1 on myogenic differentiation. E2F1 expression is irreversibly down-regulated during differentiation of C2C12 myocytes. Furthermore, deregulated E2F1 expression in C2C12 cells prevented myogenic differentiation. This inhibition of myogenesis was associated with the repression of myogenin expression and an elevated cyclin D1 expression. Moreover, E2F1-overexpressing myocytes failed to exit the cell cycle under differentiation conditions. These results are consistent with the notion that E2F1 can function as an oncogene and further suggest that E2F1 down-regulation is required for myogenic differentiation.
Insights
Cellular transcription factor E2F1 (E2F1) normally down-regulates during myocyte differentiation. Overexpression of E2F1 inhibits muscle cell differentiation by preventing cell cycle exit and repressing myogenin expression.
Area of Science:
- Molecular Biology
- Cellular Biology
- Developmental Biology
Background:
- Terminal differentiation of cultured myocytes necessitates cell cycle withdrawal.
- Oncogene overexpression in myoblasts can impede in vitro myogenesis.
Purpose of the Study:
- To investigate the role of the cellular transcription factor E2F1 in myogenic differentiation.
- To determine if E2F1 down-regulation is essential for myogenesis.
Main Methods:
- Studied E2F1 expression during differentiation of C2C12 myocytes.
- Examined the effects of deregulated E2F1 expression on myogenesis in C2C12 cells.
- Assessed myogenin and cyclin D1 expression levels.
Main Results:
- E2F1 expression was irreversibly down-regulated during C2C12 myocyte differentiation.
- Deregulated E2F1 expression inhibited myogenesis, repressed myogenin, and elevated cyclin D1.
- E2F1-overexpressing myocytes failed to exit the cell cycle under differentiation conditions.
Conclusions:
- E2F1 functions as an oncogene, inhibiting myogenic differentiation.
- E2F1 down-regulation is a required event for successful myogenic differentiation.
More Related Videos
09:16Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
12:19Stable Knockdown of Genes Encoding Extracellular Matrix Proteins in the C2C12 Myoblast Cell Line Using Small-Hairpin (sh)RNA
Published on: February 12, 2020
Related Concept Videos
Negative Regulator Molecules
Cell Specific Gene Expression
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Master Transcription Regulators
Mitogens and the Cell Cycle
Forced Transdifferentiation
Artificial transdifferentiation occurs...